Foghorn Therapeutics, Inc. (FHTX)
2.015
-0.04
(-1.71%)
USD |
NASDAQ |
Nov 13, 11:12
Foghorn Therapeutics Net Income (Annual) : -74.28M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -74.28M |
| December 31, 2024 | -86.62M |
| December 31, 2023 | -98.43M |
| December 31, 2022 | -108.88M |
| Date | Value |
|---|---|
| December 31, 2021 | -101.32M |
| December 31, 2020 | -68.80M |
| December 31, 2019 | -51.13M |
| December 31, 2018 | -26.34M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Anavex Life Sciences Corp. | -46.38M |
| Vaxcyte, Inc. | -766.63M |
| Connect Biopharma Holdings Ltd. | -55.48M |
| Caribou Biosciences, Inc. | -148.12M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |